India Highlights "Public Interest" To Reign In Prices For Non-Scheduled Drugs
This article was originally published in PharmAsia News
Executive Summary
India's National Pharmaceutical Pricing Authority has imposed a 15-day deadline on 11 drug manufacturers to rein in costs of certain drugs, citing the "public interest" of lower prices for consumers